Europe Faces Climate Onslaught, FDA Boosts Infant Formula Safety, ELREXFIO Shows Promise in Myeloma, AI Tool Redefines Obesity Risk, and more...

Europe Faces Climate Onslaught, FDA Boosts Infant Formula Safety, ELREXFIO Shows Promise in Myeloma, AI Tool Redefines Obesity Risk, and more...

April 30, 2026 · 12 min

About this episode

This episode covers urgent climate challenges in Europe, FDA safety measures for infant formula, promising myeloma treatment results, an innovative AI tool for obesity risk, and an upcoming satellite launch.

(0:10): Europe's 2025 Climate Extremes Demand Urgent Action: Heatwaves, Water Crisis, and Energy Challenges (2:15): FDA Enhances Infant Formula Safety with New Testing and Transparency Measures (4:24): Pfizer's ELREXFIO Shows Promising Results in Phase 3 Trial for Relapsed Multiple Myeloma (7:07): New AI Tool Obscore Revolutionizes Obesity Risk Detection, Prioritizes Early Intervention Over BMI Reliance (9:14): Ariane 6 Set to Launch 32 Amazon Leo Satellites on Ambitious VA268 Mission To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: logo

More episodes of Science News Daily

Explore listener stats, chart rankings, contacts and more on the Science News Daily podcast page.